ClinConnect ClinConnect Logo
Search / Trial NCT01162759

Home Blood Pressure Monitoring Project

Launched by KAISER PERMANENTE · Jul 13, 2010

Trial Information

Current as of May 13, 2025

Completed

Keywords

Hypertension, Intervention

ClinConnect Summary

STUDY OBJECTIVES:

Primary:

• To determine the proportion of patients in each group who achieve their target BP goals at 6 months, according to national clinical practice guidelines

Secondary:

The following parameters will be evaluated between groups:

* Change in BP measures between baseline and at 6 months
* Proportion of patients who are receiving antihypertensive treatments in accordance to national clinical practice guidelines
* Adherence to hypertensive medication regimen during the 6-month follow-up period
* Patient satisfaction with the care model.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Age 18 to 85 years At least 1 diagnosis for hypertension,
  • Receive primary care from one of the participating clinics,
  • The two most recent BPs documented within that last 24 months are elevated (SBP\>140 and/or DBP\>90)
  • Receiving \< 3 antihypertensive medications, and
  • Have access to a computer with a USB port.
  • Exclusion Criteria:
  • Pregnant, or breast-feeding,
  • Patients on dialysis or being followed by nephrology,
  • Patients with coronary artery disease, given these patients are already followed by the Clinical Pharmacy Cardiac Risk Service (CPCRS),
  • On KPCO "Do Not Call" or deceased list,
  • PCP does not give permission to include patient in the study,
  • BP is at or below target at the baseline study visit,
  • Not English-speaking.

About Kaiser Permanente

Kaiser Permanente is a leading integrated health care organization that combines a health plan with a network of hospitals and physicians to provide comprehensive medical services. With a strong commitment to advancing medical research and improving patient care, Kaiser Permanente sponsors clinical trials across various therapeutic areas. The organization emphasizes innovative approaches to health care, leveraging its extensive data and resources to support evidence-based treatments and enhance patient outcomes. Through its rigorous research initiatives, Kaiser Permanente aims to contribute to the advancement of medical knowledge and the development of new therapies that benefit diverse populations.

Locations

Denver, Colorado, United States

Patients applied

0 patients applied

Trial Officials

David J Magid, MD, MPH

Principal Investigator

Kaiser Permanente

Kari Olson, PharmD

Principal Investigator

Kaiser Permanente

Sarah J Billups, PharmD

Principal Investigator

Kaiser Permanente

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials